These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2764011)
1. Most-favored-nation clauses and monopsonistic power: an unhealthy mix? Stenger SE Am J Law Med; 1989; 15(1):111-28. PubMed ID: 2764011 [TBL] [Abstract][Full Text] [Related]
2. A competitive analysis of most favored nations clauses in contracts between health care providers and insurers. Celnicker A Spec Law Dig Health Care (Mon); 1991 Dec; (154):7-36. PubMed ID: 10115476 [TBL] [Abstract][Full Text] [Related]
3. The development of preferred provider organizations and its antitrust implications. Maram BS J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825 [TBL] [Abstract][Full Text] [Related]
4. Department of Justice challenging big insurers' "Most Favored Nation" clauses. Stepovich M Health Care Law Newsl; 1995 Sep; 10(9):3-4. PubMed ID: 10144889 [TBL] [Abstract][Full Text] [Related]
5. Antitrust implications of chiropractic Peer Review Committees. Volper V Am J Law Med; 1982; 8(1):45-68. PubMed ID: 7124747 [TBL] [Abstract][Full Text] [Related]
6. Antitrust and the new competition in health care: excerpts. Ginsburg DH Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459 [No Abstract] [Full Text] [Related]
8. The antitrust swamp: how can healthcare professionals avoid it? Weller CD Healthc Financ Manage; 1982 Oct; 36(10):26-8, 30-6. PubMed ID: 10315211 [No Abstract] [Full Text] [Related]
9. Can provider antitrust suits against payers be successful? Enders RJ Healthc Financ Manage; 1986 Jun; 40(6):72-80. PubMed ID: 10276682 [TBL] [Abstract][Full Text] [Related]
10. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny. Allen HS; Rothschild IS Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389 [No Abstract] [Full Text] [Related]
11. Competition in health insurance markets. Pauly MV Law Contemp Probl; 1988; 51(2):237-71. PubMed ID: 10295964 [No Abstract] [Full Text] [Related]
12. Potential anticompetitive effects of most favored nation contract clauses in managed care and health insurance contracts. Dennis AJ Ann Health Law; 1995; (4):71-85. PubMed ID: 10143197 [No Abstract] [Full Text] [Related]
13. The FTC and provider-controlled PPO price negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(3):6-10. PubMed ID: 10285716 [No Abstract] [Full Text] [Related]
14. Antitrust and physician payment. Pollard MR N C Med J; 1984 Apr; 45(4):227-31. PubMed ID: 6585668 [No Abstract] [Full Text] [Related]
15. Alternative delivery systems are focus of antitrust scrutiny. Scammon DL; Fuller DA; Sheffet MJ J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715 [No Abstract] [Full Text] [Related]
16. The sleeping giant awakens: the physician and the antitrust laws. Hirsh HL Leg Med; 1985; ():334-56. PubMed ID: 3835424 [No Abstract] [Full Text] [Related]
17. Proposed FTC consent order first to prohibit PPO price-fixing and concerted negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(2):9-10, 14. PubMed ID: 10285312 [No Abstract] [Full Text] [Related]
18. How MFN clauses used in the health care industry unreasonably restrain trade under the Sherman Act. Wright BA J Law Health; 2003-2004; 18(1):29-55. PubMed ID: 16521890 [TBL] [Abstract][Full Text] [Related]